Thursday 14 June 2018

The Brewery, London EC1


Headline sponsor:


London branch:
150 Cheapside



Stifel is a US-incorporated, NYSE-listed institutional wealth manager and investment bank, focused on the middle market. It provides strategic advisory services to its clients in North America, Europe and Asia that include initiating, structuring and negotiating mergers, acquisitions and divestitures, as well as providing fairness opinions, valuation, and restructuring services. It raises equity and public and private debt for its clients through its institutional and retail brokerage network. Stifel has a strategic emphasis globally on the healthcare sector, with senior bankers focused across all products, based in Europe and North America.



Consilium Strategic Communications
41 Lothbury
t: +44 (0)20 3709 5700


Consilium Strategic Communications

Consilium Strategic Communications is an international advisory firm specialising in healthcare strategic communications. From offices in Europe and across the US, Consilium's highly skilled team provides long-term advice to healthcare companies, Boards, senior decision makers and executives on critical communications programmes, investor relations and stakeholder challenges.


7 Ensign House 
Admirals Way
E14 9XQ

Tel: +44 (0)20 7536 2000

Design Portfolio

For over 25 years Design Portfolio has been helping quoted companies communicate effectively and efficiently. We consult with and support a wide variety of corporate clients from FTSE100 to AIM, as well as private companies and those new to market. Sectors in which we can demonstrate specialist knowledge include life sciences, healthcare, medtech and biotech.

We work in print, digital and moving image across six core areas: 

  • Annual Reports 
  • Investor presentations 
  • Corporate websites 
  • Video and animation 
  • Sustainability communications 
  • Corporate branding 

Our blend of considered creativity and expert consultancy is delivered by expert teams through a local, personal and hands-on service with offices in London, Leeds, Cambridge, Edinburgh and Miami.


FTI Consulting
200 Aldersgate

Tel: +44 20 3727 1000
Email: lifescienceslondon


FTI Consulting

FTI Consulting provides holistic, strategic communications advice to life science and healthcare companies. As the long‑standing market leader, our global team of over 50 life science experts advise a broad array of firms across the sector, both those listed on the principal stock markets worldwide as well as a growing portfolio of companies that are privately held. With a global footprint in key hubs in Europe and North America, we are ideally positioned to advise companies undertaking dual listings.

We now offer a wide range of services including: financial communications, transaction communications (M&A and fundraisings), media relations, investor relations, corporate and brand communications, issues and reputation management (including handling activist investors), internal communications and employee engagement, digital communications, and public affairs.


Instinctif Partners provides a full service communications consultancy focused on science-based sectors.

65 Gresham Street

Tel: +44 (0) 20 7457 2020

Instinctif Partners 

Instinctif Partners is an international business communications consultancy. Over three decades we have built a track record of delivering strategic counsel and insightful and creative programmes, focused on enhancing the value proposition for companies seeking investment, partnerships or customers. Our core skill is working with clients to communicate the value of their science and innovation to key stakeholders through the most relevant channels, crafting communications solutions that showcase each company, product or technology. Specifically, we are unique in offering specialist expertise seamlessly across corporate, financial, healthcare and marketing communications with outreach programmes to media, industry, professional, public, financial and investment communities. Headquartered in London, our globally integrated and dedicated Life Sciences team serves clients around the world from our bases in the EU, the US and Asia-Pacific.


To contact one of our offices: 

Bavariaring 26
80336 München, Germany
Phone +49-89-210228-0

Kaiser-Friedrich-Ring 5
40545 Düsseldorf, Germany
Phone +49-211-529252-0

Or email us at:

MC Services AG 

MC Services is an international public relations and investor relations firm specialising in communications for the life sciences and healthcare sectors. A strong team of science, finance, media and communication experts with extensive industry experience positions MC Services as the leading life sciences agency in Europe. MC Services' long-standing clients include international public and private companies as well as venture capitalists and investment firms. Established for many years as a link between the healthcare industry and the financial markets, MC Services provides comprehensive services in investor relations, public relations and financial transactions. MC Services is based in Munich, Düsseldorf, London and Boston.


NIBC Bank N.V.
Gustav Mahlerlaan 348

Tel: +31 6 21 16 18 06

NIBC Bank N.V.

NIBC offers corporate and investment banking services to mid-market clients in Europe. In August 2017, the bank expanded its focus sectors with life sciences when Oscar Izeboud and Jean-Paul Mannie joined the firm. Their extensive transaction track record in equity capital markets and M&A builds on years of experience and strong ties to the international biotech community. The Life Sciences team at NIBC can offer the full range of advisory and financing services, from ECM and M&A to mezzanine equity and leveraged and senior debt. This integrated multi-product approach results in tailor-made solutions for our clients in their decisive financial moments. For an overview of solutions that NIBC offers, please have a look at:


40 Gracechurch Street 
2nd Floor

Tel: +44 (0) 20 3861 6625
Fax: +44 (0) 20 7600 5975

Northland Capital Partners

Northland Capital Partners is a well-established independent institutional stockbroker and corporate finance adviser. We provide broking and advisory services to quoted growth companies and facilitate access to capital.

Driven by our broad network of investors and wide expertise across multiple sectors, our team has established a proven track record in raising funds for corporate clients. We pride ourselves on a commercial approach which ensures that our clients achieve their growth ambitions.

Healthcare is Northland’s fastest growing sector. Our clients cover a range of areas including generics, medtech, biotech and pharma.


9 Devonshire Square 

Optimum Strategic Communications  

Optimum is an international strategic healthcare communications firm, specialising in investor relations and corporate and financial communications.

Our team of healthcare specialists, based in London and New York, have worked together for many years. We are experienced and trusted advisers to some of the world’s most exciting public and private companies across pharmaceuticals, medtech, biotech, digital health and healthcare services, large and small. We work with companies from across Europe, providing support on strategic communications. We have advised on numerous cross-border transactions and have supported IPOs on the London Stock Exchange, Euronext and Nasdaq.


Panmure is a corporate and institutional stockbroker and investment bank.

Panmure Gordon & Co
One New Change

Tel: +44 (0) 20 7886 2500 

Panmure Gordon

Panmure Gordon is a leading independent stockbroker and investment bank specialising in corporate advice, M&A and institutional investment for the UK’s most ambitious and successful companies. Our deep healthcare knowledge and expertise has assisted clients to IPO, raise development capital and complete successful M&A transactions.

Our clients value our breadth of sector knowledge, track record and tailored, integrated service that is relationship led and outcome driven.


Peel Hunt is an independent, full-service specialist broking and advisory house, focused on UK mid and small caps, with a leading Healthcare and Life Sciences franchise.

Moor House
120 London Wall

Tel: +44 (0) 20 7418 8900
Fax: +44 (0) 20 7418 8848

Peel Hunt 

Peel Hunt is an independent, full-service specialist broking and advisory house with a focus on UK mid and small-cap companies. Our partnership structure, over 25 years of profitability, extensive trading platform and focus on long-term client relationships set us apart from our peers. We have expertise across a broad range of sectors and seek to offer high-quality advice, ideas-led research and flawless execution within a team-based and collegiate environment. Peel Hunt benefits from a powerful distribution platform and since 2015 we have completed over 150 ECM transactions (including 31 IPOs), raising over £10bn. We have over 120 retained corporate clients and continue to grow strongly.

Our Healthcare and Life Sciences team comprises dedicated sector specialists across research, sales and corporate with unparalleled access to small, mid and larger-cap investors across the UK, Europe and North America. We represent companies in the sector with an aggregate market capitalisation of over £5bn. 
Peel Hunt LLP is authorised and regulated by the Financial Conduct Authority.


Shore Capital Markets, a division
of Shore Capital Group, is an independent securities business with a large and extensive research and sales capability offering comprehensive distribution to institutions and mid and small cap companies.

Dr Tara Raveendran 
Healthcare Research 
Tel: +44 (0) 20 7647 8142

Shore Capital 

Shore Capital is a leading independent securities business offering institutional and corporate clients advisory, broking, research, sales and trading services with offices in London, Edinburgh and Liverpool.

We provide comprehensive access to institutions and mid and small-cap companies offering innovative and valued advice to quoted and private companies.

We are one of the largest market makers in the London market and have been involved in transactions raising more than £3.2bn in equity capital since January 2015.

Shore Capital’s Healthcare team provides high-quality research coverage with in-depth, detailed, insightful analysis across the entire UK healthcare spectrum incorporating major pharma, specialty pharma, medical devices, life sciences and healthcare services. Our healthcare research is distributed to over 300 UK and European institutions.